Live feed
·
INSIDERFilingvia Quantisnow
Chemours Company logo

Chemours (CC) director Keohane received 14,096 shares

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

Sean D Keohane (director at Chemours Company, CC) reported that they received 14,096 shares on Apr 22, 2025. After these transactions the filing shows 63,872.13 shares held directly.

Reporting person
Keohane Sean D
Common stock and other non-derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Apr 22, 2025Grant or award (A)Common Stock1, 2+14,096--63,872.1309 direct

Holdings before and after

  • Common Stock: 49,776.1309 to 63,872.1309 direct

Footnotes from the filing

  1. 1. Represents stock units that will convert one-for-one to Chemours common stock upon separation from service on the board.
  2. 2. Includes directly owned shares, stock units and dividend equivalent units.

Transaction codes in this filing

Grant or award:
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ

What did Keohane report in this CC Form 4?

Sean D Keohane (director at Chemours Company, CC) reported that they received 14,096 shares on Apr 22, 2025. After these transactions the filing shows 63,872.13 shares held directly.

How many CC shares does Keohane hold after this filing?

The filing shows 63,872.13 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.

What does transaction code A mean on an SEC Form 4?

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

Historical context for CC

Earlier insider filings at CC

Quantisnow market dataNYSE
Chemours Company logo
CC
Chemours Company
Market cap
30-day
Sector
Industrials
Industry
Major Chemicals
Listed since
2015
Get push alerts for CC

Follow CC and get a push notification the moment its next story breaks.

Full CC profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CC (Chemours Company) and more on Quantisnow.